Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C S Landefeld

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Mayo Clinic Proceedings|August 1, 1995
Outcomes of warfarin therapy: lessons from the real worldR J Beyth, C S Landefeld
Journal of General Internal Medicine|April 1, 1996
Using the biopsychosocial model in practice. Improving the care of patients with late-life depressionK E Covinsky, C S Landefeld
JAMA|December 28, 1994
A cost analysis of topical drug regimens for dermatophyte infectionsM M Chren, C S Landefeld
Annals of Internal Medicine|May 15, 1992
Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospitalC S Landefeld, P A Anderson
The American Journal of Medicine|September 1, 1993
Anticoagulant-related bleeding: clinical epidemiology, prediction, and preventionC S Landefeld, R J Beyth
JAMA|March 2, 1994
Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formularyM M Chren, C S Landefeld
Archives of Internal Medicine|January 11, 1993
Do older Medicare patients cost hospitals more? Evidence from an academic medical centerG E Rosenthal, C S Landefeld
Journal of General Internal Medicine|October 1, 1996
Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of viewC S Landefeld, M M Chren
Endocrinology and Metabolism Clinics of North America|March 1, 1997
Health services research and the endocrinologistD C Aron, C S Landefeld
Rhode Island Medical Journal|December 1, 1991
Doctors, drug companies and giftsM M Chren, C S Landefeld
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Mayo Clinic Proceedings|August 1, 1995
Outcomes of warfarin therapy: lessons from the real worldR J Beyth, C S Landefeld
Journal of General Internal Medicine|April 1, 1996
Using the biopsychosocial model in practice. Improving the care of patients with late-life depressionK E Covinsky, C S Landefeld
JAMA|December 28, 1994
A cost analysis of topical drug regimens for dermatophyte infectionsM M Chren, C S Landefeld
Annals of Internal Medicine|May 15, 1992
Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospitalC S Landefeld, P A Anderson
The American Journal of Medicine|September 1, 1993
Anticoagulant-related bleeding: clinical epidemiology, prediction, and preventionC S Landefeld, R J Beyth
JAMA|March 2, 1994
Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formularyM M Chren, C S Landefeld
Archives of Internal Medicine|January 11, 1993
Do older Medicare patients cost hospitals more? Evidence from an academic medical centerG E Rosenthal, C S Landefeld
Journal of General Internal Medicine|October 1, 1996
Drug companies and information about drugs: recommendations for doctors. Characteristics of materials distributed by drug companies: four points of viewC S Landefeld, M M Chren
Endocrinology and Metabolism Clinics of North America|March 1, 1997
Health services research and the endocrinologistD C Aron, C S Landefeld
Rhode Island Medical Journal|December 1, 1991
Doctors, drug companies and giftsM M Chren, C S Landefeld
Pageof 9